Home » Topics » BioWorld Science

BioWorld Science
RSS

CGeneTech identifies new CDK inhibitors

Jan. 27, 2022

Cadila Healthcare synthesizes ENPP2 inhibitors

Jan. 27, 2022

Array BioPharma discloses new HER2 inhibitors

Jan. 27, 2022

Zealand Pharma divulges LPAM-1 antagonists

Jan. 27, 2022

Discovery of novel mGlu4 receptor PAMs with antipsychotic-like properties

Jan. 27, 2022

TRAF6 loss linked to development of myeloid malignancies

Jan. 27, 2022

Exon-skipping antisense oligonucleotides show promise for treating cystic fibrosis

Jan. 27, 2022

S2K146 protects against SARS-CoV-2 infection in preclinical models

Jan. 27, 2022

MAP-tau map of interactions shows more than microtubules

Jan. 26, 2022

Tumorad significantly reduces tumor growth and prolongs survival in colorectal cancer model

Jan. 26, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...